Predictors of AMD treatment response

Ophthalmology. 2012 Nov;119(11):2413-2414.e5. doi: 10.1016/j.ophtha.2012.06.056.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Bevacizumab
  • Female
  • Humans
  • Intravitreal Injections
  • Male
  • Prognosis
  • Prospective Studies
  • Ranibizumab
  • Subretinal Fluid*
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Wet Macular Degeneration / diagnosis*
  • Wet Macular Degeneration / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab